4JFO | A2 HLA complex with E1A heteroclitic variant of Melanoma peptide | date | 2013-02-28 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Rizkallah, P.J., Cole, D.K., Madura, F., Sewell, A.K., Baker, B.M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.11 | ||||||||||||
ligand | GOL, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | T-cell receptor specificity maintained by altered thermodynamics., Madura F, Rizkallah PJ, Miles KM, Holland CJ, Bulek AM, Fuller A, Schauenburg AJ, Miles JJ, Liddy N, Sami M, Li Y, Hossain M, Baker BM, Jakobsen BK, Sewell AK, Cole DK, J Biol Chem. 2013 May 22. PMID:23698002 |
Data retrieval |
View 4JFO in 3D |
Visual 3D analysis of 4JFO |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4JFO |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |